LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 245

Search options

  1. Article ; Online: Amnesia, Superior Altitudinal Anopia, and Reversed Clock Phenomenon due to Bilateral Posterior Cerebral Artery Infarcts.

    Jindal, Jenelle A / Le, Scheherazade T / Lansberg, Maarten G

    Stroke

    2024  

    Language English
    Publishing date 2024-04-25
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80381-9
    ISSN 1524-4628 ; 0039-2499 ; 0749-7954
    ISSN (online) 1524-4628
    ISSN 0039-2499 ; 0749-7954
    DOI 10.1161/STROKEAHA.123.045669
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Insole Pressure Sensors to Assess Post-Stroke Gait.

    Nam, Hyung Seok / Clancy, Caitlin / Smuck, Matthew / Lansberg, Maarten G

    Annals of rehabilitation medicine

    2024  Volume 48, Issue 1, Page(s) 42–49

    Abstract: Objective: To confirm that the simplified insole does not affect the gait speed and to identify objective sensor-based gait parameters that correlate strongly with existing clinical gait assessment scales.: Methods: Ten participants with gait ... ...

    Abstract Objective: To confirm that the simplified insole does not affect the gait speed and to identify objective sensor-based gait parameters that correlate strongly with existing clinical gait assessment scales.
    Methods: Ten participants with gait impairment due to hemiplegic stroke were enrolled in this study. Pairs of insoles with four pressure sensors on each side were manufactured and placed in each shoe. Data were extracted during the 10-Meter Walk Test. Several sensor-derived parameters (for example stance time, heel_on-to-toe_peak time, and toe_peak pressure) were calculated and correlated with gait speed and lower extremity Fugl-Meyer (F-M) score.
    Results: The insole pressure sensor did not affect gait, as indicated by a strong correlation (ρ=0.988) and high agreement (ICC=0.924) between the gait speeds with and without the insole. The parameters that correlated most strongly with highest β coefficients against the clinical measures were stance time of the non-hemiplegic leg (β=-0.87 with F-M and β=-0.95 with gait speed) and heel_on-to-toe_peak time of the non-hemiplegic leg (β=-0.86 with F-M and -0.94 with gait speed).
    Conclusion: Stance time of the non-hemiparetic leg correlates most strongly with clinical measures and can be assessed using a non-obtrusive insole pressure sensor that does not affect gait function. These results suggest that an insole pressure sensor, which is applicable in a home environment, may be useful as a clinical endpoint in post-stroke gait therapy trials.
    Language English
    Publishing date 2024-01-11
    Publishing country Korea (South)
    Document type Journal Article
    ZDB-ID 2659431-6
    ISSN 2234-0653 ; 2234-0645
    ISSN (online) 2234-0653
    ISSN 2234-0645
    DOI 10.5535/arm.23064
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Rates and reasons for hospital readmission after acute ischemic stroke in a US population-based cohort.

    Zhou, Lily W / Lansberg, Maarten G / de Havenon, Adam

    PloS one

    2023  Volume 18, Issue 8, Page(s) e0289640

    Abstract: Hospital readmissions following stroke are costly and lead to worsened patient outcomes. We examined readmissions rates, diagnoses at readmission, and risk factors associated with readmission following acute ischemic stroke (AIS) in a large United States ...

    Abstract Hospital readmissions following stroke are costly and lead to worsened patient outcomes. We examined readmissions rates, diagnoses at readmission, and risk factors associated with readmission following acute ischemic stroke (AIS) in a large United States (US) administrative database. Using the 2019 Nationwide Readmissions Database, we identified adults discharged with AIS (ICD-10-CM I63*) as the principal diagnosis. Survival analysis with Weibull accelerated failure time regression was used to examine variables associated with hospital readmission. In 2019, 273,811 of 285,451 AIS patients survived their initial hospitalization. Of these, 60,831 (22.2%) were readmitted within 2019. Based on Kaplan Meyer analysis, readmission rates were 9.7% within 30 days and 30.5% at 1 year following initial discharge. The most common causes of readmissions were stroke and post stroke sequalae (25.4% of 30-day readmissions, 15.0% of readmissions between 30-364 days), followed by sepsis (10.3% of 30-day readmissions, 9.4% of readmissions between 30-364 days), and acute renal failure (3.2% of 30-day readmissions, 3.0% of readmissions between 30-364 days). After adjusting for multiple patient and hospital-level characteristics, patients at increased risk of readmission were older (71.6 vs. 69.8 years, p<0.001) and had longer initial lengths of stay (7.6 vs. 6.2 day, p<0.001). They more often had modifiable comorbidities, including vascular risk factors (hypertension, diabetes, atrial fibrillation), depression, epilepsy, and drug abuse. Social determinants associated with increased readmission included living in an urban (vs. rural) setting, living in zip-codes with the lowest median income, and having Medicare insurance. All factors were significant at p<0.001. Unplanned hospital readmissions following AIS were high, with the most common reasons for readmission being recurrent stroke and post stroke sequalae, followed by sepsis and acute renal failure. These findings suggest that efforts to reduce readmissions should focus on optimizing secondary stroke and infection prevention, particularly among older socially disadvantaged patients.
    MeSH term(s) Adult ; Humans ; Aged ; United States/epidemiology ; Patient Readmission ; Ischemic Stroke ; Medicare ; Stroke/epidemiology ; Stroke/drug therapy ; Risk Factors ; Sepsis ; Retrospective Studies ; Databases, Factual
    Language English
    Publishing date 2023-08-03
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0289640
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Cost-Effectiveness of Cilostazol Added to Aspirin or Clopidogrel for Secondary Prevention After Noncardioembolic Stroke.

    Zhou, Lily W / Kraler, Lironn / de Havenon, Adam / Lansberg, Maarten G

    Journal of the American Heart Association

    2022  Volume 11, Issue 11, Page(s) e024992

    Abstract: Background The objective of the study was to assess the cost-effectiveness of cilostazol (a selective phosphodiesterase 3 inhibitor) added to aspirin or clopidogrel for secondary stroke prevention in patients with noncardioembolic stroke. Methods and ... ...

    Abstract Background The objective of the study was to assess the cost-effectiveness of cilostazol (a selective phosphodiesterase 3 inhibitor) added to aspirin or clopidogrel for secondary stroke prevention in patients with noncardioembolic stroke. Methods and Results A Markov model decision tree was used to examine lifetime costs and quality-adjusted life years (QALYs) of patients with noncardioembolic stroke treated with either aspirin or clopidogrel or with additional cilostazol 100 mg twice daily. Cohorts were followed until all patients died from competing risks or ischemic or hemorrhagic stroke. Probabilistic sensitivity analysis using Monte Carlo simulation was used to model 10 000 cohorts of 10 000 patients. The addition of cilostazol to aspirin or clopidogrel is strongly cost saving. In all 10 000 simulations, the cilostazol strategy resulted in lower health care costs compared with aspirin or clopidogrel alone (mean $13 488 cost savings per patient; SD, $8087) and resulted in higher QALYs (mean, 0.585 more QALYs per patient lifetime; SD, 0.290). This result remained robust across a variety of sensitivity analyses, varying cost inputs, and treatment effects. At a willingness-to-pay threshold of $50 000/QALY, average net monetary benefit from the addition of cilostazol was $42 743 per patient over their lifetime. Conclusions Based on the best available data, the addition of cilostazol to aspirin or clopidogrel for secondary prevention following noncardioembolic stroke results in significantly reduced health care costs and a gain in lifetime QALYs.
    MeSH term(s) Aspirin ; Cilostazol/therapeutic use ; Clopidogrel/therapeutic use ; Cost-Benefit Analysis ; Humans ; Markov Chains ; Platelet Aggregation Inhibitors/adverse effects ; Quality-Adjusted Life Years ; Secondary Prevention ; Stroke ; Ticlopidine/adverse effects
    Chemical Substances Platelet Aggregation Inhibitors ; Clopidogrel (A74586SNO7) ; Cilostazol (N7Z035406B) ; Ticlopidine (OM90ZUW7M1) ; Aspirin (R16CO5Y76E)
    Language English
    Publishing date 2022-06-03
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2653953-6
    ISSN 2047-9980 ; 2047-9980
    ISSN (online) 2047-9980
    ISSN 2047-9980
    DOI 10.1161/JAHA.121.024992
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Transient Complete Reversal of Large Area of Restricted Diffusion Seen Early Following Thrombectomy.

    Zhou, Lily W / Lee, Sarah / Schwartz, Neil E / Albers, Gregory W / Lansberg, Maarten G

    Stroke

    2022  Volume 53, Issue 8, Page(s) e377–e378

    MeSH term(s) Brain Ischemia ; Endovascular Procedures ; Humans ; Stroke/surgery ; Thrombectomy ; Treatment Outcome
    Language English
    Publishing date 2022-05-06
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 80381-9
    ISSN 1524-4628 ; 0039-2499 ; 0749-7954
    ISSN (online) 1524-4628
    ISSN 0039-2499 ; 0749-7954
    DOI 10.1161/STROKEAHA.122.038825
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Characteristics of Younger and Older Adults with Hospital-Acquired Delirium: a Claims Data Study Spanning 14 years.

    Rohatgi, Nidhi / Weng, Yingjie / Ahuja, Neera / Lansberg, Maarten G

    Journal of general internal medicine

    2021  Volume 36, Issue 4, Page(s) 1150–1152

    MeSH term(s) Aged ; Delirium/diagnosis ; Delirium/epidemiology ; Geriatric Assessment ; Hospitals ; Humans
    Language English
    Publishing date 2021-01-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 639008-0
    ISSN 1525-1497 ; 0884-8734
    ISSN (online) 1525-1497
    ISSN 0884-8734
    DOI 10.1007/s11606-020-06379-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: CT perfusion in acute stroke: Practical guidance for implementation in clinical practice.

    Christensen, Soren / Lansberg, Maarten G

    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

    2018  Volume 39, Issue 9, Page(s) 1664–1668

    MeSH term(s) Brain/blood supply ; Brain/diagnostic imaging ; Brain Ischemia/diagnostic imaging ; Cerebrovascular Circulation ; Contrast Media/administration & dosage ; Humans ; Radiation Dosage ; Stroke/diagnostic imaging ; Tomography, X-Ray Computed/methods
    Chemical Substances Contrast Media
    Language English
    Publishing date 2018-10-22
    Publishing country United States
    Document type Editorial
    ZDB-ID 604628-9
    ISSN 1559-7016 ; 0271-678X
    ISSN (online) 1559-7016
    ISSN 0271-678X
    DOI 10.1177/0271678X18805590
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Perioperative Stroke Risk Reduction in Patients With Patent Foramen Ovale.

    Rohatgi, Nidhi / Smilowitz, Nathaniel R / Lansberg, Maarten G

    JAMA neurology

    2020  Volume 77, Issue 12, Page(s) 1479–1480

    MeSH term(s) Foramen Ovale, Patent/complications ; Humans ; Ischemic Stroke/etiology ; Ischemic Stroke/prevention & control ; Postoperative Complications/etiology ; Postoperative Complications/prevention & control ; Risk Reduction Behavior
    Language English
    Publishing date 2020-09-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2702023-X
    ISSN 2168-6157 ; 2168-6149
    ISSN (online) 2168-6157
    ISSN 2168-6149
    DOI 10.1001/jamaneurol.2020.2619
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Factors Associated with Hospital-Acquired Delirium in Patients 18-65 Years Old.

    Rohatgi, Nidhi / Weng, Yingjie / Ahuja, Neera / Lansberg, Maarten G

    Journal of general internal medicine

    2021  Volume 36, Issue 4, Page(s) 1147–1149

    MeSH term(s) Adolescent ; Adult ; Aged ; Delirium/diagnosis ; Delirium/epidemiology ; Hospitalization ; Hospitals ; Humans ; Middle Aged ; Risk Factors ; Young Adult
    Language English
    Publishing date 2021-01-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 639008-0
    ISSN 1525-1497 ; 0884-8734
    ISSN (online) 1525-1497
    ISSN 0884-8734
    DOI 10.1007/s11606-020-06378-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Varicella Zoster Vasculopathy Exacerbated by Tofacitinib in a Patient With Ulcerative Colitis.

    Lyman, Kyle A / Sreekrishnan, Anirudh / Thatikunta, Prateek / McConnell, Ryan / Lansberg, Maarten G / Mijalski Sells, Christina M

    Stroke

    2023  Volume 54, Issue 6, Page(s) e246–e250

    MeSH term(s) Humans ; Colitis, Ulcerative/complications ; Colitis, Ulcerative/drug therapy ; Chickenpox ; Herpes Zoster/complications ; Herpes Zoster/drug therapy ; Herpesvirus 3, Human
    Chemical Substances tofacitinib (87LA6FU830)
    Language English
    Publishing date 2023-04-06
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80381-9
    ISSN 1524-4628 ; 0039-2499 ; 0749-7954
    ISSN (online) 1524-4628
    ISSN 0039-2499 ; 0749-7954
    DOI 10.1161/STROKEAHA.122.042228
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top